With roots in UC Irvine research, Eira Bio is targeting membrane proteins long considered unreachable by antibody drugs.

Check out this new paper in Nature from the Baker group and Xaira team in collaboration with K2 co-founder Chang Liu that highlights the powerful synergy between computational design and directed evolution using OrthoRep to develop precise high-affinity antibodies. Congratulations to all the authors!

Our Co-Founder, Prof. Mo Khalil, is joining the Harvard SEAS faculty as the Hok Lam and Kathleen Kam Wong Professor of Bioengineering. Congrats Mo!